| Home Forums |
|
#1
Sat Apr 19, 2014, 11:57 PM
|
|||
|
|||
|
AG-221 clinical trial
I am going to participate in the AG-221 clinical trial. It is specific to AML and MDS patients with an IDH2 gene mutation. It is phase 1 in which 6 out of 7 patients have shown positive results. Taking part in this trial will delay starting Vidaza by about a month. Any comments please.
|
 |
| Thread Tools | Search this Thread |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| New Promacta (Eltrombopag) Clinical Trial at NIH | Sally C | Clinical Trials | 73 | Sun Dec 30, 2018 06:52 AM |
| Learning About Clinical Trials and Finding Clinical Trials | Marrowforums | Clinical Trials | 0 | Wed Jun 3, 2015 06:10 PM |
| Curcumin/Gingerol Clinical Trial for MDS | Janice M. | Clinical Trials | 13 | Mon May 13, 2013 11:03 AM |
| Thank you to clinical trial participants! | Neil Cuadra | Clinical Trials | 7 | Sat Jan 12, 2013 04:49 PM |
| Clinical Trial Fibrogen 2216 | seniorrico | Clinical Trials | 2 | Sun Jan 28, 2007 01:48 PM |
